trial

The Immune System and Psychiatric Disorders

NCTId NCT00184418
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 1,400 (actual)
Sponsored by Norwegian University of Science and Technology
Primary completion 2008-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
1,400 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2005-01
Primary completion
2008-01
Eligibility
ALL

Interventions & indications

Drugs
—

Sponsors

Norwegian University of Science and TechnologyLead Sponsor
St. Olavs HospitalCollaborator

Investigators

1
Solveig Klæbo Reitan, MD, PhDStudy Chair

Sites

1 total
Trondheim, Norway

Facts & assertions

4 sourced
Enrollment
1,400
Phase
NA
Primary Completion Date
2008-01
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
Norwegian University of Science and Technology
company
collaborator
St. Olavs Hospital
company
indication
Bipolar Disorder
indication
Psychotic Disorders
indication
Depressive Disorder
indication
investigator
Solveig Klæbo Reitan, MD, PhD
person